U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Methylprednisolone Acetate Injection
Status: Currently in Shortage
»Date first posted: 12/15/2021
»Therapeutic Categories: Rheumatology

Expand all

Amneal Pharmaceuticals (Revised 07/09/2024)

Company Contact Information:
866-525-7270

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 40 mg/1 mL (NDC 70121-1573-1) Available Sufficient Inventory available (02 to 04 Wk) as per current demand. Next Supply from wk. of 14th July-24
Injection, 40 mg/1 mL (NDC 70121-1573-5) Available Sufficient Inventory available (02 to 04 Wk) as per current demand. Next Supply from wk. of 7th July-24
Injection, 80 mg/1 mL (NDC 70121-1574-1) Available Sufficient Inventory available (02 to 04 Wk) as per current demand. Next Supply from wk. of 7th July-24
Injection, 80 mg/1 mL (NDC 70121-1574-5) Available Available Inventory for 1 week as per current demand. Next Supply from wk. of 14th July-24

Eugia US LLC (Reverified 07/17/2024)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 40 mg/1 mL (NDC 55150-313-01) Available Check wholesalers for inventory
Injection, 80 mg/1 mL (NDC 55150-314-01) Unavailable On backorder. Recovery: TBD. Check wholesalers for inventory Demand increase for the drug

Par Pharmaceutical, Inc. (Reverified 07/15/2024)

Company Contact Information:
800-828-9393

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 80 mg/1 mL (NDC 42023-240-01) Unavailable Recovery: July 2024 Other

Pfizer Inc. (Revised 07/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) Available
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) Available
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) Available
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) Available
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) Available
Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) Available
Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) Available
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) Limited Availability Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024 Demand increase for the drug
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) Limited Availability Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024 Demand increase for the drug
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) Limited Availability Next Delivery: July 2024; Estimated Recovery: September 2024 Demand increase for the drug
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) Available
Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) Available
Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) Limited Availability Next Delivery: July 2024; Estimated Recovery: September 2024 Demand increase for the drug

Sagent Pharmaceuticals (Reverified 07/01/2024)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 40 mg/1 mL (NDC 25021-820-10) Available
Injection, 40 mg/1 mL (NDC 25021-820-05) Available
Injection, 80 mg/1 mL (NDC 25021-821-05) Available
Back to Top